CYTK
Price
$38.58
Change
+$1.57 (+4.24%)
Updated
Jul 14 closing price
Capitalization
4.61B
16 days until earnings call
SANA
Price
$4.22
Change
+$0.04 (+0.96%)
Updated
Jul 14 closing price
Capitalization
951.84M
16 days until earnings call
Interact to see
Advertisement

CYTK vs SANA

Header iconCYTK vs SANA Comparison
Open Charts CYTK vs SANABanner chart's image
Cytokinetics
Price$38.58
Change+$1.57 (+4.24%)
Volume$1.62M
Capitalization4.61B
Sana Biotechnology
Price$4.22
Change+$0.04 (+0.96%)
Volume$5.84M
Capitalization951.84M
CYTK vs SANA Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. SANA commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and SANA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (CYTK: $38.58 vs. SANA: $4.22)
Brand notoriety: CYTK and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 103% vs. SANA: 120%
Market capitalization -- CYTK: $4.61B vs. SANA: $951.84M
CYTK [@Biotechnology] is valued at $4.61B. SANA’s [@Biotechnology] market capitalization is $951.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than CYTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than SANA.

Price Growth

CYTK (@Biotechnology) experienced а +15.65% price change this week, while SANA (@Biotechnology) price change was +32.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.65%. For the same industry, the average monthly price growth was +18.33%, and the average quarterly price growth was +31.96%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

SANA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.61B) has a higher market cap than SANA($952M). SANA YTD gains are higher at: 158.896 vs. CYTK (-17.985). SANA has higher annual earnings (EBITDA): -195.34M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. SANA (105M). SANA has less debt than CYTK: SANA (91.3M) vs CYTK (791M). CYTK has higher revenues than SANA: CYTK (19.2M) vs SANA (0).
CYTKSANACYTK / SANA
Capitalization4.61B952M484%
EBITDA-513.62M-195.34M263%
Gain YTD-17.985158.896-11%
P/E RatioN/AN/A-
Revenue19.2M0-
Total Cash938M105M893%
Total Debt791M91.3M866%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKSANA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
78%
Bearish Trend 19 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOIX66.02N/A
N/A
Rydex Biotechnology Inv
PREIX164.65N/A
N/A
T. Rowe Price Equity Index 500
USBOX23.99N/A
N/A
Pear Tree Quality Ordinary
QUAIX71.87N/A
N/A
AB Small Cap Growth I
FAOFX18.24N/A
N/A
Fidelity Advisor Series Growth Opps

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with VIR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+0.96%
VIR - SANA
63%
Loosely correlated
-2.65%
AXON - SANA
43%
Loosely correlated
+2.83%
CPRX - SANA
42%
Loosely correlated
-0.87%
ABSI - SANA
40%
Loosely correlated
-0.37%
GBIO - SANA
39%
Loosely correlated
+13.87%
More